Significance of the Wnt signaling pathway in coronary artery atherosclerosis

Introduction The progression of coronary atherosclerosis is an active and regulated process. The Wnt signaling pathway is thought to play an active role in the pathogenesis of several cardiovascular diseases; however, a better understanding of this system in atherosclerosis is yet to be unraveled. Methods In this study, real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blotting were used to quantify the expression of Wnt3a, Wnt5a, and Wnt5b in the human coronary plaque, and immunohistochemistry was used to identify sites of local expression. To determine the pathologic significance of increased Wnt, human vascular smooth muscle cells (vSMCs) were treated with Wnt3a, Wnt5a, and Wnt5b recombinant proteins and assessed for changes in cell differentiation and function. Results RT-PCR and Western blotting showed a significant increase in the expression of Wnt3a, Wnt5a, Wnt5b, and their receptors in diseased coronary arteries compared with that in non-diseased coronary arteries. Immunohistochemistry revealed an abundant expression of Wnt3a and Wnt5b in diseased coronary arteries, which contrasted with little or no signals in normal coronary arteries. Immunostaining of Wnt3a and Wnt5b was found largely in inflammatory cells and myointimal cells. The treatment of vSMCs with Wnt3a, Wnt5a, and Wnt5b resulted in increased vSMC differentiation, migration, calcification, oxidative stress, and impaired cholesterol handling. Conclusions This study demonstrates the upregulation of three important members of canonical and non-canonical Wnt signaling pathways and their receptors in coronary atherosclerosis and shows an important role for these molecules in plaque development through increased cellular remodeling and impaired cholesterol handling.

[1]  A. Poznyak,et al.  Mechanisms of the Wnt Pathways as a Potential Target Pathway in Atherosclerosis , 2023, Journal of lipid and atherosclerosis.

[2]  A. Poole,et al.  Pro-inflammatory role of Wnt/β-catenin signaling in endothelial dysfunction , 2023, Frontiers in Cardiovascular Medicine.

[3]  C. Antoniades,et al.  Non-canonical WNT signalling in cardiovascular disease: mechanisms and therapeutic implications , 2022, Nature Reviews Cardiology.

[4]  M. Silver,et al.  Oxidized Low-Density Lipoprotein Induces WNT5A Signaling Activation in THP-1 Derived Macrophages and a Human Aortic Vascular Smooth Muscle Cell Line , 2020, Frontiers in Cardiovascular Medicine.

[5]  A. Mani,et al.  The role of Wnt signalling in development of coronary artery disease and its risk factors , 2020, Open Biology.

[6]  J. Yamamoto-Furusho,et al.  Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells. , 2020, Cellular signalling.

[7]  C. Nguyên,et al.  Convergence of Canonical and Non-canonical Wnt Signal: Differential Kat3 Coactivator Usage , 2019, Current molecular pharmacology.

[8]  M. Bennett,et al.  Vascular smooth muscle cells in atherosclerosis , 2019, Nature Reviews Cardiology.

[9]  G. Angelini,et al.  Aging differentially modulates the Wnt pro‐survival signalling pathways in vascular smooth muscle cells , 2018, Aging cell.

[10]  M. Silver,et al.  Blocking Wnt5a signaling decreases CD36 expression and foam cell formation in atherosclerosis. , 2018, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[11]  D. Tousoulis,et al.  Coronary versus carotid artery plaques. Similarities and differences regarding biomarkers morphology and prognosis , 2018, Current opinion in pharmacology.

[12]  M. Montagnana,et al.  Atherosclerosis Is an Inflammatory Disease which Lacks a Common Anti-inflammatory Therapy: How Human Genetics Can Help to This Issue. A Narrative Review , 2018, Front. Pharmacol..

[13]  I. Albanese,et al.  Atherosclerotic Calcification: Wnt Is the Hint , 2018, Journal of the American Heart Association.

[14]  W. Matthijs Blankesteijn,et al.  WNT Signaling in Cardiac and Vascular Disease , 2018, Pharmacological Reviews.

[15]  H. Shimano,et al.  SREBP-regulated lipid metabolism: convergent physiology — divergent pathophysiology , 2017, Nature Reviews Endocrinology.

[16]  A. Alsheikh-Ali,et al.  MINI-FOCUS : AORTIC VALVE DISEASE Lipoprotein ( a ) Induces Human Aortic Valve Interstitial Cell Calci fi cation , 2017 .

[17]  M. Kahn,et al.  Wnt/β-catenin activation and macrophage induction during liver cancer development following steatosis , 2017, Oncogene.

[18]  J. Tardif,et al.  Role of Noncanonical Wnt Signaling Pathway in Human Aortic Valve Calcification , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[19]  M. Boutros,et al.  Wnt signaling in cancer , 2016, Oncogene.

[20]  M. Bennett,et al.  Vascular Smooth Muscle Cells in Atherosclerosis. , 2016, Circulation research.

[21]  A. Orekhov,et al.  Macrophage‐mediated cholesterol handling in atherosclerosis , 2015, Journal of cellular and molecular medicine.

[22]  Laura S. Shankman,et al.  KLF4 Dependent Phenotypic Modulation of SMCs Plays a Key Role in Atherosclerotic Plaque Pathogenesis , 2015, Nature Medicine.

[23]  L. Badimón,et al.  LRP5 deficiency down-regulates Wnt signalling and promotes aortic lipid infiltration in hypercholesterolaemic mice , 2015, Journal of cellular and molecular medicine.

[24]  P. Bhatt,et al.  Wnt5a: a player in the pathogenesis of atherosclerosis and other inflammatory disorders. , 2014, Atherosclerosis.

[25]  Heiko Lemcke,et al.  Ca2+-mediated Mitochondrial Reactive Oxygen Species Metabolism Augments Wnt/β-Catenin Pathway Activation to Facilitate Cell Differentiation* , 2014, The Journal of Biological Chemistry.

[26]  D. Rader,et al.  Apolipoprotein A-I and cholesterol efflux: the good, the bad, and the modified. , 2014, Circulation research.

[27]  M. Sweet,et al.  Recombinant Wnt3a and Wnt5a elicit macrophage cytokine production and tolerization to microbial stimulation via Toll‐like receptor 4 , 2014, European journal of immunology.

[28]  S. Allahverdian,et al.  Contribution of Intimal Smooth Muscle Cells to Cholesterol Accumulation and Macrophage-Like Cells in Human Atherosclerosis , 2014, Circulation.

[29]  Wenwei Liu,et al.  Wnt3a activates β1-integrin and regulates migration and adhesion of vascular smooth muscle cells. , 2014, Molecular medicine reports.

[30]  G. Go,et al.  The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue. , 2014, Cell metabolism.

[31]  D. J. Goetz,et al.  Wnt5a, TLR2 and TLR4 are elevated in advanced human atherosclerotic lesions , 2013, Inflammation Research.

[32]  J. Moss,et al.  LOX-1 in atherosclerosis: biological functions and pharmacological modifiers , 2012, Cellular and Molecular Life Sciences.

[33]  R. Nusse,et al.  Wnt5a can both activate and repress Wnt/β-catenin signaling during mouse embryonic development. , 2012, Developmental biology.

[34]  S. George,et al.  Wnt signalling in smooth muscle cells and its role in cardiovascular disorders. , 2012, Cardiovascular research.

[35]  G. Go,et al.  Low-Density Lipoprotein Receptor (LDLR) Family Orchestrates Cholesterol Homeostasis , 2012, The Yale journal of biology and medicine.

[36]  C. Yabe-Nishimura,et al.  A crucial role for Nox 1 in redox‐dependent regulation of Wnt‐β‐catenin signaling , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  L. Badimón,et al.  Wnt pathway activation, cell migration, and lipid uptake is regulated by low-density lipoprotein receptor-related protein 5 in human macrophages. , 2011, European heart journal.

[38]  Matthias Nahrendorf,et al.  Molecular Imaging of Coronary Atherosclerosis and Myocardial Infarction: Considerations for the Bench and Perspectives for the Clinic , 2011, Circulation research.

[39]  F. Salvi,et al.  Carotid artery atherosclerosis in hypertensive patients with a functional LDL receptor-related protein 6 gene variant. , 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[40]  Michael Kühl,et al.  The Multiple Phases and Faces of Wnt Signaling During Cardiac Differentiation and Development , 2010, Circulation research.

[41]  D. W. Kim,et al.  Wnt5a Induces Endothelial Inflammation via β-Catenin–Independent Signaling , 2010, The Journal of Immunology.

[42]  D. J. Goetz,et al.  Wnt5a is expressed in murine and human atherosclerotic lesions. , 2008, American journal of physiology. Heart and circulatory physiology.

[43]  J. Malmquist,et al.  Regulation of In Vitro Vascular Calcification by BMP4, VEGF and Wnt3a , 2007, Calcified Tissue International.

[44]  K. Griendling,et al.  Reactive oxygen species signaling in vascular smooth muscle cells. , 2006, Cardiovascular research.

[45]  J. Genest,et al.  Cellular cholesterol homeostasis in vascular endothelial cells. , 2006, The Canadian journal of cardiology.

[46]  L. Topol,et al.  Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation , 2003, Development.

[47]  Darwin J. Prockop,et al.  In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[48]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[49]  A. Giaid,et al.  Endothelial expression of endothelial nitric oxide synthase and endothelin-1 in human coronary artery disease. Specific reference to underlying lesion. , 1999, Laboratory investigation; a journal of technical methods and pathology.